Clinical trial No longer in our active list Interventional Ages 18 to 55

Telerehabilitation for cognitive impairment in multiple sclerosis

Official title: Multicentre Randomized Blinded Controlled Study of Specific Telerehabilitation of Multidomain Cognitive Impairment in Multiple Sclerosis Using Mixed Evaluation and Ecological Validity

Run by University Hospital, Bordeaux · NCT05611047 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether a remote rehabilitation program can help people with multiple sclerosis improve their thinking skills, like memory and attention.

Quick facts

Study typeInterventional
Ages18 Years to 55 Years
SexAll
Enrollment150 (estimated)
SponsorUniversity Hospital, Bordeaux
Academic / other
Locations7 sites (Bordeaux and 6 other locations)
Trial IDNCT05611047 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are French-speaking adults aged 18-55 with a confirmed diagnosis of relapsing-remitting multiple sclerosis and specific cognitive impairments.

Probably not a fit

Patients with severe cognitive impairment or those unable to use a computer and internet may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on addressing cognitive impairment (CI) in individuals with multiple sclerosis (MS), a condition that significantly affects the quality of life and daily functioning. It employs a telerehabilitation approach, utilizing clinical assessments and cognitive evaluations to tailor interventions for participants. The study aims to improve cognitive functions such as information processing speed, attention, and memory through active procedures delivered remotely. Participants will be monitored and assessed using standardized cognitive tests to evaluate the effectiveness of the intervention.

Why it matters

Potential benefit: If successful, this approach could enhance cognitive functioning and overall quality of life for patients with multiple sclerosis.

How similar studies have gone: Other studies have shown promising results with telerehabilitation approaches for cognitive impairment, indicating potential for success in this novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female;
* Age 18-55 years;
* Native French speaking;
* Definite diagnosis of Relapsing-remitting MS (RRMS) according to McDonald 2017 criteria;
* Disease duration\> 12 months and ≤ 15 years;
* Computerized-Screening Cognitive Test (CSCT) score ≤ - 1.282 Standard Deviations (SD) (10th percentile) and/or cognitive complaint;
* 3 scores -1 SDa or 2 scores -1.5 SDb at least 2 of 5 baseline preselection neuropsychological battery tests in one of the following domains: processing speed or attention or working memory (SDMT, subtests alert, divided attention, visual scanning for selective attention, TAP and subtest working memory of the WAIS IV) and SDMT score not ≤ -3 SD;
* Able to use a computer with Windows operating system, an internet connection;
* Being affiliated to health insurance
* Having signed an informed consent (at the latest on the day of inclusion and before any examination required by research)

Exclusion Criteria:

* Previous history of other neurological disease;
* Psychiatric comorbidity including severe depression according to Diagnostic and Statistical Manual-IV (DSM-IV);
* Current dependence on alcohol or other addiction to toxic;
* Disabling visual or motor problems preventing participation to neuropsychological assessments;
* Change of psychotropic drug or disease-modifying therapies since less than one month;
* MS relapse in the month preceding the inclusion visit
* Illiteracy, ie: unable to count or to read;
* Acquisition disorders: dyslexia, dysphasia, dyscalculia and dyspraxia;
* Pregnant or breastfeeding women;
* Patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent).

Where it's running

  • CHU de Bordeaux - Service de neurologie
    Bordeaux, France
    Recruiting
  • CHU de Clermont-Ferrand - Service de neurologie
    Clermont-Ferrand, France
    Not yet recruiting
  • CHU de Dijon-Bourgogne - Service de neurologie
    Dijon, France
    Not yet recruiting
  • CH de Dunkerque - Service de neurologie
    Dunkerque, France
    Not yet recruiting
  • Hôpital Saint Vincent de Paul - Service de neurologie
    Lille, France
    Not yet recruiting
  • CHU de Montpellier - Service de neurologie
    Montpellier, France
    Not yet recruiting
Show 1 more location
  • CHI Hôpital de Poissy Saint Germain en Laye - Service de neurologie
    Poissy, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.